Objectives: Non-exposed endoscopic full-thickness resection (EFTR) using a dedicated full-thickness resection device (FTRD) can be used to perform en bloc resection of subepithelial lesions throughout the gastrointestinal tract. Here we aim to evaluate the safety and efficacy of EFTR for the management of duodenal neuroendocrine tumors (dNET).
Methods: International multicenter retrospective study of device assisted EFTR for dNET.
Background And Aims: Endoscopy makes a significant contribution to the carbon footprint of healthcare. A randomized trial (RESECT-COLON) demonstrated that Endoscopic Submucosal Dissection (ESD) decreases the recurrence rate of large adenomas (>25 mm) versus piecemeal Endoscopic Mucosal Resection (P-EMR), reducing the need for follow-up colonoscopy. We aimed to compare the carbon footprint of those 2 strategies.
View Article and Find Full Text PDF